NIV and HFNO are premier non-invasive modalities for acute hypoxemic and hypercapnic respiratory failure, reducing intubation rates and ICU mortality.

Key Physiological Equations & Formulas

  • ROX Index in Adults (FLORALI Trial):

    $$\text{ROX} = \frac{SpO_2 / FiO_2}{RR}$$

    ROX >= 4.88 calculated at 2, 6, and 12 hours predicts HFNO success; ROX < 3.85 predicts high failure risk and need for intubation.

  • HACOR Score for NIV Failure:

    $$\text{HACOR} = \text{Heart Rate} + \text{Acidosis (pH)} + \text{Consciousness (GCS)} + \text{Oxygenation (P/F)} + \text{Respiratory Rate}$$

    HACOR score > 5 at 1-2 hours predicts NIV failure with >85% accuracy.

Practical Clinical Pearls & Bedside Rules

  • Gold Standard Indications for NIV: 1. Acute hypercapnic respiratory failure in COPD exacerbation ($pH < 7.35, PaCO_2 > 45$), 2. Acute cardiogenic pulmonary edema (ACPE).
  • HFNO Mechanisms: Delivers up to 60 L/min heated humidified gas: dead-space washout, low-level PEEP ($0.5-1\text{ cmH}_2\text{O}$ per $10\text{ L/min}$), and precise FiO2 delivery.

Initial Settings & Clinical Titration Protocol

ParameterRecommended Initial SettingTitration Goal / Safety Threshold
NIV IPAP/EPAPStart IPAP 10-12 / EPAP 4-5 cmH2O (titrate to IPAP 16-20)Target tidal volume 6-8 mL/kg and reduction in tachypnea.
HFNO FlowStart 50-60 L/min with FiO2 1.0 (titrate FiO2 down to maintain SpO2 92-96%)Maximize dead space washout.

Bedside Troubleshooting & Red Flags

Warning

Delayed Intubation in Decompensating Patients: Do not continue failing NIV/HFNO in patients with worsening acidosis, exhaustion, or encephalopathy; intubate without delay.

Key Takeaways & Summary

  1. Always evaluate patient synchrony and physiological response before changing ventilator parameters.
  2. Maintain lung-protective strategies to minimize driving pressure ($\Delta P$) and mechanical power.
  3. Continuously reassess liberation and extubation readiness on daily morning rounds.